Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Targeting lysosomes to eradicate imatinib-resistant chronic myelogenous leukemia cells.

Targeting lysosomes to eradicate imatinib-resistant chronic myelogenous leukemia cells. Leukemia. 2010 May; 24(5):1099-101.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.